Skip to content

Company information lookup


Developer of innovative treatments for cancer and diseases of the central nervous system.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BNO 0.475 -3.06% 0.470 0.475 0.480 0.480 0.475 10,765


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BNO
Official Listing Date 21 December, 1999
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address 31 Dalgleish Street, THEBARTON, SA, AUSTRALIA, 5031
Head Office Telephone 08 8354 6100
Head Office Fax 08 8354 6199
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Graeme Kaufman (Chairman)
Dr Deborah Rathjen (Managing Director, CEO)
Dr Errol De Souza (Non Exec. Director)
Dr Jonathan Lim (Non Exec. Director)
Mr Trevor Tappenden (Non Exec. Director)
Ms Melanie Young (CFO)
Company Secretary Ms Melanie Young
Principal Activities Developer of innovative treatments for cancer and diseases of the central nervous system.


How are company announcements published on

Date Price
Headline Pages PDF
26/11/2014   Appendix 3B 12 PDF
24/11/2014   Change of Director's Interest Notice 2 PDF
20/11/2014   Amended Change of Director's Interest Notice 3 PDF
20/11/2014   BNC101 Data Presented at European Cancer Conference 2 PDF
18/11/2014   Change of Director's Interest Notice 2 PDF
18/11/2014   Appendix 3B 12 PDF
18/11/2014   Change of Director's Interest Notice 2 PDF
17/11/2014   BNC210 Data To Be Presented At US Conference 2 PDF
12/11/2014   Annual General Meeting 2014 Results 2 PDF
12/11/2014   CEO & Managing Director's AGM Presentation 2014 27 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
26 Nov 2014 0.490 2.08% 0.490 0.480 36,741
25 Nov 2014 0.480 0% 0.490 0.465 148,280
24 Nov 2014 0.480 -2.04% 0.500 0.480 44,798
21 Nov 2014 0.490 1.03% 0.510 0.490 86,300
20 Nov 2014 0.485 -5.83% 0.515 0.485 79,704

* Volume of shares shown represents only those shares traded on ASX.

BIONOMICS LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security BNO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNO

Warrants & Structured Products

No warrants & Structured Products are available over the security BNO